Cargando…
Serum miR‐92a‐1 is a novel diagnostic biomarker for colorectal cancer
Colorectal cancer (CRC) is one of the most common cancers worldwide, with high mortality. Abnormally expressed microRNAs (miRNAs) are considered novel biomarkers in cancer diagnosis. The aim of this study was to investigate the diagnostic value of miR‐92a‐1 in patients with CRC. Serum samples were c...
Autores principales: | Shi, Ying, Liu, Zhibao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7412696/ https://www.ncbi.nlm.nih.gov/pubmed/32562465 http://dx.doi.org/10.1111/jcmm.15282 |
Ejemplares similares
-
MiR-92a Family: A Novel Diagnostic Biomarker and Potential Therapeutic Target in Human Cancers
por: Jiang, Min, et al.
Publicado: (2019) -
Loss of Circulating Exosomal miR-92b is a Novel Biomarker of Colorectal Cancer at Early Stage
por: Min, Li, et al.
Publicado: (2019) -
The diagnostic effect of serum miR-196b as biomarker in colorectal cancer
por: Xu, Chunjie, et al.
Publicado: (2017) -
Evaluation of Serum miR-17-92 Cluster as Noninvasive Biomarkers for Bladder Cancer Diagnosis
por: Wang, Jingyao, et al.
Publicado: (2021) -
Circulating miR-92a, miR-143 and miR-342 in Plasma are Novel Potential Biomarkers for Acute Myeloid Leukemia
por: Elhamamsy, Amr Rafat, et al.
Publicado: (2017)